CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 135 enrolled
Drug / intervention
Standard-of-care medical treatment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05017753
NCT05017753N/ACompleted

Thoracentesis to Alleviate Cardiac Pleural Effusion - an Interventional Trial (TAP-IT)

Bispebjerg Hospital·interventional·Posted Aug 24, 2021·Updated Dec 13, 2024

In Brief

A clinical study evaluating Thoracentesis and Standard-of-care medical treatment for Heart Failure and Pleural Effusion. Completed, enrolled 135 participants across 10 sites.

Detailed Summary

The present study will examine the comparative effectiveness of two treatment strategies currently used in the treatment of patients with systolic heart failure presenting with pleural effusion. Patients will be randomized to standard medical treatment only or medical treatment and referral to thoracentesis. Study hypothesis: A strategy of referring patients with heart failure-related pleural effusion to thoracentesis increases number of days alive outside of hospital over the following 90 days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 24, 2021
Enrollment StartAug 31, 2021
Primary CompletionMar 22, 2024
Study CompletionDec 11, 2024
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 4.9 years ago

Interventions

Thoracentesisprocedure

Thoracentesis will be performed according to local practice, either at the ward or at the radiology department, in addition to standard-of-care medical treatment.

Standard-of-care medical treatmentdrug

Standard-of-care medical treatment